Literature DB >> 30235004

Unified platform for multimodal voxel-based analysis to evaluate tumour perfusion and diffusion characteristics before and after radiation treatment evaluated in metastatic brain cancer.

Catherine Coolens1,2,3,4, Brandon Driscoll1, Warren Foltz1,2, Igor Svistoun1, Noha Sinno1,3, Caroline Chung4,5.   

Abstract

OBJECTIVE: : Early changes in tumour behaviour following stereotactic radiosurgery) are potential biomarkers of response. To-date quantitative model-based measures of dynamic contrast-enhanced (DCE) and diffusion-weighted (DW) MRI parameters have shown widely variable findings, which may be attributable to variability in image acquisition, post-processing and analysis. Big data analytic approaches are needed for the automation of computationally intensive modelling calculations for every voxel, independent of observer interpretation.
METHODS: : This unified platform is a voxel-based, multimodality architecture that brings complimentary solute transport processes such as perfusion and diffusion into a common framework. The methodology was tested on synthetic data and digital reference objects and consequently evaluated in patients who underwent volumetric DCE-CT, DCE-MRI and DWI-MRI scans before and after treatment. Three-dimensional pharmacokinetic parameter maps from both modalities were compared as well as the correlation between apparent diffusion coefficient (ADC) values and the extravascular, extracellular volume (Ve). Comparison of histogram parameters was done via Bland-Altman analysis, as well as Student's t-test and Pearson's correlation using two-sided analysis.
RESULTS: : System testing on synthetic Tofts model data and digital reference objects recovered the ground truth parameters with mean relative percent error of 1.07 × 10-7 and 5.60 × 10-4 respectively. Direct voxel-to-voxel Pearson's analysis showed statistically significant correlations between CT and MR which peaked at Day 7 for Ktrans (R = 0.74, p <= 0.0001). Statistically significant correlations were also present between ADC and Ve derived from both DCE-MRI and DCE-CT with highest median correlations found at Day 3 between median ADC and Ve,MRI values (R = 0.6, p < 0.01) The strongest correlation to DCE-CT measurements was found with DCE-MRI analysis using voxelwise T10 maps (R = 0.575, p < 0.001) instead of assigning a fixed T10 value.
CONCLUSION: : The unified implementation of multiparametric transport modelling allowed for more robust and timely observer-independent data analytics. Utility of a common analysis platform has shown higher correlations between pharmacokinetic parameters obtained from different modalities than has previously been reported. ADVANCES IN KNOWLEDGE:: Utility of a common analysis platform has shown statistically higher correlations between pharmacokinetic parameters obtained from different modalities than has previously been reported.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30235004      PMCID: PMC6540849          DOI: 10.1259/bjr.20170461

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  30 in total

1.  Rapid high-resolution T(1) mapping by variable flip angles: accurate and precise measurements in the presence of radiofrequency field inhomogeneity.

Authors:  Hai-Ling Margaret Cheng; Graham A Wright
Journal:  Magn Reson Med       Date:  2006-03       Impact factor: 4.668

2.  Candidate biomarkers of extravascular extracellular space: a direct comparison of apparent diffusion coefficient and dynamic contrast-enhanced MR imaging--derived measurement of the volume of the extravascular extracellular space in glioblastoma multiforme.

Authors:  S J Mills; C Soh; C J Rose; S Cheung; S Zhao; G J M Parker; A Jackson
Journal:  AJNR Am J Neuroradiol       Date:  2009-10-22       Impact factor: 3.825

3.  On the scope and interpretation of the Tofts models for DCE-MRI.

Authors:  Steven P Sourbron; David L Buckley
Journal:  Magn Reson Med       Date:  2011-03-07       Impact factor: 4.668

4.  Implementation and characterization of a 320-slice volumetric CT scanner for simulation in radiation oncology.

Authors:  C Coolens; S Breen; T G Purdie; A Owrangi; J Publicover; S Bartolac; D A Jaffray
Journal:  Med Phys       Date:  2009-11       Impact factor: 4.071

Review 5.  The seed and soil hypothesis: vascularisation and brain metastases.

Authors:  Isaiah J Fidler; Seiji Yano; Ruo-Dan Zhang; Takahashi Fujimaki; Corazon D Bucana
Journal:  Lancet Oncol       Date:  2002-01       Impact factor: 41.316

6.  Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations.

Authors:  Anwar R Padhani; Guoying Liu; Dow Mu Koh; Thomas L Chenevert; Harriet C Thoeny; Taro Takahara; Andrew Dzik-Jurasz; Brian D Ross; Marc Van Cauteren; David Collins; Dima A Hammoud; Gordon J S Rustin; Bachir Taouli; Peter L Choyke
Journal:  Neoplasia       Date:  2009-02       Impact factor: 5.715

7.  Morphological and functional MRI, MRS, perfusion and diffusion changes after radiosurgery of brain metastasis.

Authors:  Tae Wook Kang; Sung Tae Kim; Hong Sik Byun; Pyoung Jeon; Keonha Kim; Hyungjin Kim; Jung Ii Lee
Journal:  Eur J Radiol       Date:  2008-10-01       Impact factor: 3.528

8.  Experimentally-derived functional form for a population-averaged high-temporal-resolution arterial input function for dynamic contrast-enhanced MRI.

Authors:  Geoff J M Parker; Caleb Roberts; Andrew Macdonald; Giovanni A Buonaccorsi; Sue Cheung; David L Buckley; Alan Jackson; Yvonne Watson; Karen Davies; Gordon C Jayson
Journal:  Magn Reson Med       Date:  2006-11       Impact factor: 4.668

Review 9.  Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols.

Authors:  P S Tofts; G Brix; D L Buckley; J L Evelhoch; E Henderson; M V Knopp; H B Larsson; T Y Lee; N A Mayr; G J Parker; R E Port; J Taylor; R M Weisskoff
Journal:  J Magn Reson Imaging       Date:  1999-09       Impact factor: 4.813

10.  Use of dynamic contrast-enhanced MRI to evaluate acute treatment with ZD6474, a VEGF signalling inhibitor, in PC-3 prostate tumours.

Authors:  D Checkley; J J Tessier; J Kendrew; J C Waterton; S R Wedge
Journal:  Br J Cancer       Date:  2003-11-17       Impact factor: 7.640

View more
  3 in total

1.  Accuracy and Performance of Functional Parameter Estimation Using a Novel Numerical Optimization Approach for GPU-Based Kinetic Compartmental Modeling.

Authors:  Igor Svistoun; Brandon Driscoll; Catherine Coolens
Journal:  Tomography       Date:  2019-03

Review 2.  Transformational Role of Medical Imaging in (Radiation) Oncology.

Authors:  Catherine Coolens; Matt N Gwilliam; Paula Alcaide-Leon; Isabella Maria de Freitas Faria; Fabio Ynoe de Moraes
Journal:  Cancers (Basel)       Date:  2021-05-23       Impact factor: 6.639

3.  Integration of quantitative imaging biomarkers in clinical trials for MR-guided radiotherapy: Conceptual guidance for multicentre studies from the MR-Linac Consortium Imaging Biomarker Working Group.

Authors:  Petra J van Houdt; Hina Saeed; Daniela Thorwarth; Clifton D Fuller; William A Hall; Brigid A McDonald; Amita Shukla-Dave; Ernst S Kooreman; Marielle E P Philippens; Astrid L H M W van Lier; Rick Keesman; Faisal Mahmood; Catherine Coolens; Teodor Stanescu; Jihong Wang; Neelam Tyagi; Andreas Wetscherek; Uulke A van der Heide
Journal:  Eur J Cancer       Date:  2021-06-15       Impact factor: 10.002

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.